Oral Immediate‑Release Morphine Dosing and Titration Guidelines

Initial Dosing Strategy

Opioid‑naïve adults should start with 5 mg of immediate‑release oral morphine every 4 hours, with an identical 5 mg dose available for breakthrough pain as often as hourly. 3
Patients previously treated with weak opioids should start with 10 mg of immediate‑release oral morphine every 4 hours, with the same 10 mg dose for breakthrough pain. 3

Total daily morphine consumption (scheduled + breakthrough doses) must be reviewed every 24 hours. Steady‑state plasma concentrations are reached within this interval (≈4–5 half‑lives). 1, 5, 6
If more than four breakthrough doses are required in a day, increase the baseline scheduled dose. 7
When pain recurs before the next scheduled dose, increase the regular dose rather than shortening the dosing interval. 1, 2, 6
Scheduled immediate‑release morphine must never be administered more frequently than every 4 hours. 1, 2, 6

The breakthrough dose should be equal to the regular 4‑hourly dose (not a fraction). This full dose provides better analgesia, and any dose‑related adverse effects from a single rescue dose are clinically insignificant. 1, 2, 5
The European Association for Palliative Care guideline recommends the full 4‑hourly dose, contrary to the ESMO suggestion of 10 % of the total daily dose. 7

Once pain is stable on immediate‑release morphine, convert to a modified‑release formulation for convenience. 1, 2, 3
Calculate the total 24‑hour morphine requirement and divide by two to obtain the 12‑hourly modified‑release dose. 1, 2, 3
Continue immediate‑release morphine for breakthrough pain at one‑third of the 12‑hourly modified‑release dose (equivalent to the previous 4‑hourly dose). 1, 2, 5
Administer a double dose of immediate‑release morphine at bedtime (1.5–2 × the daytime dose) to prevent nocturnal pain awakening; this practice is widely adopted and effective without causing problems. 1, 2, 5, 6

Prescribe a stimulant laxative (e.g., senna) prophylactically at the time of morphine initiation to prevent constipation, the most persistent opioid adverse effect. 8
Provide an antiemetic (e.g., haloperidol) concurrently or in anticipation to mitigate nausea and vomiting. 7
Initial drowsiness, dizziness, and mental clouding typically resolve within a few days of starting therapy. 5, 3

Oral administration is the preferred route for morphine. If oral intake is impossible, sub‑cutaneous administration is the preferred alternative. 1, 2, 3
The oral‑to‑sub‑cutaneous potency ratio is approximately 2 : 1 to 3 : 1 (e.g., 20–30 mg oral ≈ 10 mg sub‑cutaneous). 3

Tramadol and codeine have limited utility due to dose‑titration constraints and drug‑interaction risks; they should be used cautiously. 8

Do not initiate therapy with modified‑release morphine for dose titration unless immediate‑release morphine is unavailable. 1, 2, 3
If modified‑release morphine is started, dose adjustments should not occur more frequently than every 48 hours. 3
Never increase dosing frequency (e.g., giving immediate‑release morphine every 2–3 hours); instead, increase the dose itself. 1, 2, 6
Avoid predetermined dose increments; titrate based on the patient’s actual total daily consumption. 1, 5

Provide written instructions that clearly delineate scheduled versus breakthrough doses, including timing, drug names, and amounts. 1, 2